Jorg van Loosdregt

5.8k citations

46 papers · 2.2k indexed · h-index 23

Co-authors: Paul J. Coffer Sebastiaan J. Vastert Berent J. Prakken Cornelis P. J. Bekker Andrea Gröne Alice J.A.M. Sijts Dietmar M. Zaiss Arjan B. Brenkman
Topics: Immune Cell Function and Interaction (20 papers)T-cell and B-cell Immunology (14 papers)Autoimmune and Inflammatory Disorders Research (10 papers)
Cited by: Immunology Hematology Geriatrics and Gerontology
Journals: Circulation Nature Communications Blood
Partner nations: Netherlands United States Germany

In The Last Decade

Jorg van Loosdregt

45 papers receiving 2.2k citations

Peers

Countries citing papers authored by Jorg van Loosdregt

Since Specialization

Citations

This map shows the geographic impact of Jorg van Loosdregt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorg van Loosdregt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorg van Loosdregt more than expected).

Fields of papers citing papers by Jorg van Loosdregt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorg van Loosdregt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorg van Loosdregt. The network helps show where Jorg van Loosdregt may publish in the future.

Co-authorship network of co-authors of Jorg van Loosdregt

This figure shows the co-authorship network connecting the top 25 collaborators of Jorg van Loosdregt. A scholar is included among the top collaborators of Jorg van Loosdregt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorg van Loosdregt. Jorg van Loosdregt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nicotinamide Inhibits CD4+ T-Cell Activation and Function 2025 ·Cells ·(unknown),(unknown),Rianne C. Scholman,(unknown),(unknown),Enric Mocholí,(unknown),Jorg J. A. Calis,Michal Mokrý,Sebastiaan J. Vastert,Jorg van Loosdregt	0
2	N6-methyladenosine promotes TNF mRNA degradation in CD4+ T lymphocytes 2024 ·Journal of Leukocyte Biology ·(unknown),(unknown),Rianne C. Scholman,(unknown),(unknown),(unknown),Michal Mokrý,(unknown),Robert Jan Lebbink,Enric Mocholí,Paul J. Coffer,Jorg J. A. Calis,Sebastiaan J. Vastert,Jorg van Loosdregt	2
3	m6A Reader YTHDC1 Impairs Respiratory Syncytial Virus Infection by Downregulating Membrane CX3CR1 Expression 2024 ·Viruses ·(unknown),(unknown),Rianne C. Scholman,(unknown),Rupa Banerjee,(unknown),(unknown),Michiel van der Vlist,Marvin E. Tanenbaum,Robert Jan Lebbink,Sebastiaan J. Vastert,Jorg van Loosdregt	7
4	Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis 2023 ·Frontiers in Immunology ·Arjan Boltjes,(unknown),Maud Plantinga,Michal Mokrý,Bas Castelijns,Joost F. Swart,Sebastiaan J. Vastert,Menno P. Creyghton,Stefan Nierkens,Jorg van Loosdregt,Femke van Wijk	5
5	The clinical and experimental treatment of Juvenile Idiopathic Arthritis 2023 ·Clinical & Experimental Immunology ·(unknown),Joost F. Swart,(unknown),Jorg van Loosdregt,Sebastiaan J. Vastert	3
6	N6-Methyladenosine Directly Regulates CD40L Expression in CD4+ T Lymphocytes 2023 ·Biology ·(unknown),(unknown),Rianne C. Scholman,(unknown),Michal Mokrý,(unknown),Robert Jan Lebbink,Jorg J. A. Calis,Sebastiaan J. Vastert,Jorg van Loosdregt	9
7	Epigenetic changes in inflammatory arthritis monocytes contribute to disease and can be targeted by JAK inhibition 2023 ·Lara D. Veeken ·Janneke G. C. Peeters,Arjan Boltjes,Rianne C. Scholman,Stephin J. Vervoort,Paul J. Coffer,Michal Mokrý,Sebastiaan J. Vastert,Femke van Wijk,Jorg van Loosdregt	5
8	Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation 2021 ·Nature Communications ·Gerdien Mijnheer,(unknown),Michal Mokrý,Marlot van der Wal,Rianne C. Scholman,Veerle Fleskens,Aridaman Pandit,Weiyang Tao,(unknown),Stephin J. Vervoort,Ceri A. Roberts,Alessandra Petrelli,Janneke G. C. Peeters,(unknown),Sytze de Roock,Sebastiaan J. Vastert,Leonie S. Taams,Jorg van Loosdregt,Femke van Wijk	57
9	ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal Fibroblasts 2021 ·Journal of Investigative Dermatology ·Chiara Angiolilli,Emmerik F A Leijten,Cornelis P. J. Bekker,(unknown),Barbara Giovannone,(unknown),Marlot van der Wal,Judith L. Thijs,Sebastiaan J. Vastert,Femke van Wijk,Timothy R. D. J. Radstake,Jorg van Loosdregt	24
10	Kinesin-4 KIF21B limits microtubule growth to allow rapid centrosome polarization in T cells 2020 ·eLife ·Peter Jan Hooikaas,(unknown),(unknown),Wilhelmina E. van Riel,Maud Martin,(unknown),Jorg van Loosdregt,Lukas C. Kapitein,Florian Berger,Anna Akhmanova	31
11	Molecular mechanisms of autophagic memory in pathogenic T cells in human arthritis 2018 ·Journal of Autoimmunity ·Pavanish Kumar,Jing Yao Leong,(unknown),Bhairav Paleja,Jorg van Loosdregt,Camillus Chua,Thaschawee Arkachaisri,Alessandro Consolaro,Marco Gattorno,Alberto Martini,Ken D. Pischel,Gary W. Williams,Martin Lotz,Salvatore Albani	12
12	Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression 2015 ·Cell Reports ·Janneke G. C. Peeters,Stephin J. Vervoort,Sander Tan,Gerdien Mijnheer,Sytze de Roock,Sebastiaan J. Vastert,Edward E. S. Nieuwenhuis,Femke van Wijk,(unknown),Menno P. Creyghton,Paul J. Coffer,Michal Mokrý,Jorg van Loosdregt	82
13	Autoimmune disease-associated gene expression is reduced by BET-inhibition 2015 ·Genomics Data ·Janneke G. C. Peeters,Stephin J. Vervoort,Gerdien Mijnheer,Sytze de Roock,Sebastiaan J. Vastert,Edward E. S. Nieuwenhuis,Femke van Wijk,Berent J. Prakken,Michal Mokrý,Jorg van Loosdregt	7
14	FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2 2015 ·Oncogene ·Veerle Fleskens,Michal Mokrý,Anne M. van der Leun,(unknown),Cornelieke Pals,Janneke G. C. Peeters,Samuel Coenen,Bruno A. Cardoso,João T. Barata,Jorg van Loosdregt,Paul J. Coffer	8
15	A circulating reservoir of pathogenic-like CD4+ T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment 2014 ·Annals of the Rheumatic Diseases ·Roberto Spreafico,Maura Rossetti,Jorg van Loosdregt,Carol A. Wallace,Margherita Massa,Silvia Magni‐Manzoni,Marco Gattorno,Alberto Martini,Daniel J. Lovell,Salvatore Albani	55
16	Post-translational modification networks regulating FOXP3 function 2014 ·Trends in Immunology ·Jorg van Loosdregt,Paul J. Coffer	79
17	Early adipogenesis is regulated through USP7-mediated deubiquitination of the histone acetyltransferase TIP60 2013 ·Nature Communications ·Yuan Gao,Arjen Koppen,Maryam Rakhshandehroo,(unknown),Stan F.J. van de Graaf,Jorg van Loosdregt,Olivier van Beekum,Nicole Hamers,Dik van Leenen,Celia R. Berkers,Ruud Berger,Frank C. P. Holstege,Paul J. Coffer,Arjan B. Brenkman,Huib Ovaa,Eric Kalkhoven	55
18	Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells 2011 ·Blood ·Ellen J. Wehrens,Gerdien Mijnheer,Chantal L. Duurland,Mark Klein,Jenny Meerding,Jorg van Loosdregt,Wilco de Jager,Birgit Sawitzki,Paul J. Coffer,Sebastiaan J. Vastert,Berent J. Prakken,Femke van Wijk	119
19	Syntenin-mediated regulation of Sox4 proteasomal degradation modulates transcriptional output 2011 ·Oncogene ·Jeffrey M. Beekman,Stephin J. Vervoort,(unknown),(unknown),(unknown),Anna Brugulat-Panés,Jorg van Loosdregt,A. Koen Braat,Paul J. Coffer	38
20	Rapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1 2011 ·PLoS ONE ·Jorg van Loosdregt,Diede Brunen,Veerle Fleskens,Cornelieke Pals,Eric W.‐F. Lam,Paul J. Coffer	97

About Jorg van Loosdregt

Jorg van Loosdregt is a scholar working on Immunology, Hematology and Physiology, having authored 46 papers that have together received 2.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (20 papers), T-cell and B-cell Immunology (14 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). The work is most often cited by research in Immunology (1.2k citations), Hematology (300 citations) and Geriatrics and Gerontology (66 citations). Jorg van Loosdregt has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Paul J. Coffer, Sebastiaan J. Vastert, Berent J. Prakken, Cornelis P. J. Bekker, Andrea Gröne, Alice J.A.M. Sijts, Dietmar M. Zaiss, Arjan B. Brenkman, Eric Kalkhoven and Veerle Fleskens. Their work appears in journals such as Circulation, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact